HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuo Kitagawa Selected Research

Methylphenazonium Methosulfate

12/2016Serine racemase inhibition induces nitric oxide-mediated neurovascular protection during cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuo Kitagawa Research Topics

Disease

47Stroke (Strokes)
09/2022 - 09/2002
39Ischemic Stroke
07/2022 - 04/2005
24Ischemia
12/2016 - 01/2002
21Infarction (Infarctions)
09/2021 - 02/2004
15Atherosclerosis
07/2022 - 02/2002
15Hypertension (High Blood Pressure)
01/2021 - 02/2003
14Brain Ischemia (Cerebral Ischemia)
12/2016 - 04/2002
10Hemorrhage
07/2022 - 01/2014
9Atrial Fibrillation
09/2021 - 05/2004
9Carotid Artery Diseases
10/2014 - 06/2002
8Cerebral Infarction
08/2021 - 06/2002
7Myocardial Infarction
01/2020 - 09/2009
6Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
04/2018 - 08/2004
5Embolic Stroke
09/2021 - 01/2013
5Lacunar Stroke
05/2020 - 06/2002
5Embolism (Embolus)
12/2019 - 09/2005
5Type 2 Diabetes Mellitus (MODY)
01/2019 - 12/2009
5Dementia (Dementias)
11/2018 - 01/2010
5Inflammation (Inflammations)
10/2017 - 05/2003
4Pathologic Constriction (Stenosis)
07/2022 - 05/2003
4Acute Coronary Syndrome
04/2022 - 01/2014
4Parkinson Disease (Parkinson's Disease)
01/2021 - 06/2015
4Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 04/2006
4Transient Ischemic Attack
05/2019 - 08/2005
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 01/2014
4Thrombosis (Thrombus)
01/2013 - 09/2005
3Dyslipidemias (Dyslipidemia)
07/2022 - 01/2014
3Intracranial Hemorrhages (Intracranial Hemorrhage)
09/2021 - 09/2015
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2020 - 08/2019
3Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2018 - 09/2004
3Hyperlipidemias (Hyperlipidemia)
04/2018 - 02/2014
3Diabetes Mellitus
04/2018 - 01/2017
3Cerebral Small Vessel Diseases
01/2016 - 04/2005
3Hemorrhagic Stroke
09/2015 - 01/2011
2Hypertriglyceridemia
07/2022 - 01/2022
2Neuromyelitis Optica (Devic's Disease)
01/2021 - 01/2018
2Neoplasms (Cancer)
01/2021 - 01/2013
2Myasthenia Gravis
01/2020 - 04/2019
2Hypercholesterolemia
05/2019 - 01/2018
2Fabry Disease (Fabry's Disease)
01/2019 - 01/2019
2Brain Infarction
01/2019 - 04/2005
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2019 - 01/2018
2Cognitive Dysfunction
11/2018 - 01/2010
2Glioma (Gliomas)
11/2018 - 01/2018
2Lymphoma (Lymphomas)
01/2018 - 02/2004
2Intracranial Embolism
01/2013 - 05/2009

Drug/Important Bio-Agent (IBA)

19Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 11/2007
14Clopidogrel (Plavix)FDA Link
07/2022 - 11/2009
12Pravastatin (Pravachol)FDA LinkGeneric
06/2020 - 11/2007
12C-Reactive ProteinIBA
05/2019 - 03/2004
9Prasugrel HydrochlorideFDA Link
02/2021 - 01/2014
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2022 - 05/2004
8LDL CholesterolIBA
01/2022 - 01/2018
7Warfarin (Coumadin)FDA LinkGeneric
09/2021 - 09/2005
7AnticoagulantsIBA
09/2021 - 09/2005
6Glutamic Acid (Glutamate)FDA Link
12/2020 - 04/2002
6Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2002
6Oxygen (Dioxygen)IBA
12/2016 - 09/2002
6Apolipoproteins E (ApoE)IBA
01/2016 - 02/2002
5Cilostazol (Pletal)FDA LinkGeneric
07/2022 - 09/2011
5EnzymesIBA
07/2022 - 10/2003
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
09/2021 - 09/2005
5Glucose (Dextrose)FDA LinkGeneric
01/2018 - 02/2007
5Interleukin-6 (Interleukin 6)IBA
10/2014 - 03/2004
5Antihypertensive Agents (Antihypertensives)IBA
01/2011 - 01/2005
4omega-Chloroacetophenone (Mace)IBA
09/2022 - 01/2014
4Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
10/2013 - 08/2007
3LDL Lipoproteins (beta Lipoproteins)IBA
05/2020 - 01/2018
3CholesterolIBA
01/2020 - 02/2014
3Tissue Plasminogen Activator (Alteplase)FDA Link
01/2020 - 05/2012
3InterleukinsIBA
01/2018 - 10/2012
3Neuroprotective AgentsIBA
12/2016 - 04/2002
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2014 - 08/2010
3Pharmaceutical PreparationsIBA
12/2014 - 11/2009
3Pioglitazone (Actos)FDA Link
01/2014 - 12/2009
3Interleukin-18 (Interleukin 18)IBA
02/2013 - 07/2005
3Bromodeoxyuridine (BrdU)IBA
05/2007 - 03/2002
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2005 - 02/2002
3ApolipoproteinsIBA
11/2002 - 02/2002
2Triglycerides (Triacylglycerol)IBA
07/2022 - 01/2022
2SteroidsIBA
01/2021 - 02/2019
2Immunoglobulin G (IgG)IBA
01/2021 - 01/2018
2HDL CholesterolIBA
01/2020 - 04/2018
2edoxabanIBA
12/2019 - 09/2015
2oxidized low density lipoproteinIBA
05/2019 - 01/2018
2Cytochrome P-450 CYP2C19IBA
01/2019 - 01/2016
2Vitamin KFDA Link
11/2018 - 09/2015
2Methionine (L-Methionine)FDA Link
11/2018 - 02/2007
2Nylons (Nylon)IBA
04/2018 - 04/2005
2LipidsIBA
01/2018 - 01/2018
2HomocysteineIBA
01/2016 - 06/2002
2N-Methylaspartate (NMDA)IBA
12/2014 - 08/2010
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2014 - 03/2011
2Angiotensin Receptor AntagonistsIBA
12/2013 - 03/2010
2fibrin fragment D (D-dimer)IBA
01/2013 - 01/2013

Therapy/Procedure

31Therapeutics
07/2022 - 09/2004
5Secondary Prevention
12/2019 - 09/2009
4Percutaneous Coronary Intervention
01/2016 - 01/2014
2Enzyme Replacement Therapy
01/2019 - 01/2019
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2014 - 01/2014